ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "HIV virus"

  • 2017 American Transplant Congress

    Low Incidence of Acute Rejection within the Six Months After Transplantation in HIV Recipients Treated with Raltegravir, the ANRS 153 Treve Trial.

    M. Matignon,1 A. Lahiani,9 J. Lelievre,2 D. Desvaux,6 K. Abassi,9 A. Diallo,9 M. Peraldi,7 A. Taburet,4 J. Saillard,5 C. Delaugerre,3 L. Assoumou,9 P. Grimbert,1 TREVE ANRS Study Group.5

    1Nephrology, APHP Henri Mondor, Créteil, France; 2Immunology, APHP Henri Mondor, Créteil, France; 3Virology, APHP Saint Louis, Paris, France; 4Pharmacology, APHP, Le Kremlin-Bicêtre, France; 5ANRS, Paris, France; 6Anatomopathology, APHP Henri Mondor, Créteil, France; 7Nephrology, APHP Saint Louis, Paris, France; 8UMR_S 1136, Paris, France

    Renal transplantation is safe and effective in HIV patients with end stage renal disease (ESRD). High rates of acute rejection (AR) have been reported because…
  • 2017 American Transplant Congress

    Antiretroviral Therapy Modification of HIV+ Patients Listed for Kidney Transplantation.

    D. Lee,1 G. Malat,3 T. Bias,1 S. Epstein,1 L. Levin Mizrahi,2 M. Harhay,2 S. Talluri,2 K. Ranganna.2

    1Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia; 2Division of Nephrology, Drexel University College of Medicine, Philadelphia; 3Department of Surgery, Drexel University College of Medicine, Philadelphia

    Introduction:HIV+ individuals can receive kidney transplant (KT) safely and effectively but face additional challenges from potential drug interactions between antiretroviral therapy (ART) and immunosuppression(IS). Little…
  • 2017 American Transplant Congress

    Nonmelanoma Skin Cancer Rates Are Not Affected by Chronic HIV(+) or HCV(+) Infection in Organ Transplant Recipients.

    K. Nadhan, E. Usedom, S. Shipman, A. Doyle, G. Malat, E. Buchanan, C. Chung.

    Dermatology, Drexel, Philadelphia

    Purpose: HIV and HCV are two immune dysregulatory processes that may exacerbate the risk of nonmelanoma skin cancer (NMSC) in organ transplant recipients (OTR), a…
  • 2017 American Transplant Congress

    Emerging Variables Which May Enhance Care of HIV Positive Renal Transplant Recipients.

    D. Leonard, M. Prendergast.

    Transplantation, Mayo Clinic, Jacksonville, FL

    Purpose: Single center experience of kidney and pancreas transplantation in the HIV positive populationMethods: Retrospective data and outcomes analysis of HIV positive kidney and pancreas…
  • 2017 American Transplant Congress

    Willingness to Donate Organs Among Persons Living with HIV.

    S. Halpern, K. Kumar, A. Nguyen, S. Rasmussen, S. Anjum, A. Massie, A. Tobian, D. Segev, J. Sugarman, C. Durand.

    JHU, Baltimore, MD

    HIV-to-HIV organ transplants could shorten waitlist times among both HIV-infected (HIV+) and uninfected (HIV-) individuals. However, it is unknown whether HIV+ individuals are willing to…
  • 2017 American Transplant Congress

    Immune Activation and Rejection Risk in HIV-Positive Kidney Transplantation.

    S. Wisel, B. Shaw, L. Lee, K. Lee, C. Leung, P. Stock, Q. Tang.

    Division of Transplantation, University of California, San Francisco, San Francisco, CA

    Purpose: HIV+ kidney transplant recipients experience higher rates of rejection episodes when compared to HIV- recipients. We hypothesize that this early, aggressive rejection is associated…
  • 2017 American Transplant Congress

    Long-Term Outcomes in HIV(+) Kidney Re-Tranpslant (ReTx) Recipients vs. Primary Transplant (PrimTx) Recipients.

    G. Malat, S. Guy, K. Ranganna, D. Reich, G. Xiao, S. Talluri, M. Harhay, L. Levin Mizrahi, C. Culkin.

    Drexel University College of Medicine, Philadelphia

    Hahnemann University Hospital has performed 113 kidney transplants, including 7 ReTx. Herein we describe characteristics and allograft outcomes of HIV(+) kidney transplant recipients based on…
  • 2017 American Transplant Congress

    Live Donor (LDTx) HIV(+) Kidney Transplantation Improves Allograft Survival vs. Deceased Donor (CRD) Transplantation.

    G. Malat, D. Lee, K. Ranganna, S. Talluri, L. Levin Mizrahi, M. Harhay, C. Culkin, S. Guy.

    Drexel University College of Medicine, Philadelphia

    Hahnemann University Hospital has performed 113 kidney transplants in HIV(+) recipients. We sought to analyze the impact of HIV(+) LDTx on allograft survival.Methods: The HIV(+)…
  • 2016 American Transplant Congress

    Kidney Retransplantation Is Associated with Higher Mortality Risk Among HIV+ vs. HIV- Recipients.

    B. Shelton,1 S. Mehta,1 D. Sawinski,2 R. Reed,1 P. MacLennan,1 S. Gustafson,3 C. Durand,4 D. Segev,4 J. Locke.1

    1School of Medicine, University of Alabama at Birmingham, Birmingham, AL; 2School of Medicine, University of Pennsylvania, Philadelphia, PA; 3Scientific Registry of Transplant Recipients, Minneapolis, MN; 4School of Medicine, Johns Hopkins University, Baltimore, MD.

    Background: Excellent outcomes have been demonstrated in HIV+ kidney transplant (KT) recipients, yet no study has explored outcomes among HIV+ reKT recipients.Methods: 4,683 adult reKT…
  • 2016 American Transplant Congress

    Lower Renal Graft Function and Accelerated Fibrosis in HIV-Infected Transplant Recipients with Previous HIVAN Compared to Non HIVAN HIV-Positive Transplant Recipients.

    M.-N. Peraldi,1 H. Ayari,1 M. Burbach,1 C. Randoux,2 E. Pillebout,1 N. De Castro,3 J.-M. Molina,3 D. Glotz.1

    1Nephrologie et Transplantation, Hôpital Saint-Louis et Université Paris-Diderot, Paris, France; 2Néphrologie, Hôpital Bichat et Université Paris-Diderot, Paris, France; 3Service de Maladies Infectieuses, Hôpital Saint-Louis et Université Paris-Diderot, Paris, France.

    Several studies reported reduced renal allograft survival rates among HIV-infected transplant recipients. Few data focus on histological lesions and their progression in renal grafts from…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences